Connect for Cancer Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify factors that might increase or decrease cancer risk. Researchers focus on the roles of lifestyle, genetics, and health history in contributing to cancer risk. Participants will share health surveys, provide biological samples such as blood and saliva, and allow access to their health records over time. The trial seeks adults aged 30 to 70 who have never had invasive cancer. Joining this study could help uncover important insights for future cancer prevention. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to significant advancements in cancer prevention.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on collecting health data and samples rather than altering your current treatment.
Why are researchers excited about this trial?
Researchers are excited about the Connect for Cancer Prevention Study because it aims to uncover valuable insights into cancer prevention by observing people over time. Unlike traditional treatments that focus on addressing cancer after it develops, this study seeks to understand the factors that contribute to preventing cancer in the first place. By gathering comprehensive data on lifestyle, environment, and genetic factors, researchers hope to identify new strategies to reduce cancer risk and improve early detection methods. This approach has the potential to transform how we think about cancer prevention and could lead to breakthroughs in reducing cancer incidence.
Who Is on the Research Team?
Nicolas A Wentzensen, M.D.
Principal Investigator
National Cancer Institute (NCI)
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Enrollment and Initial Data Collection
Participants create an account, complete informed consent, and provide initial health surveys and biological samples
Ongoing Data Collection
Participants provide repeated exposure information and biological specimens, and share electronic health records
Follow-up
Participants are monitored for cancer incidence, progression, and mortality
What Are the Treatments Tested in This Trial?
Interventions
- Observational Study
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Cancer Institute (NCI)
Lead Sponsor